Transgenic expression of CD95 ligand on thyroid follicular cells confers immune privilege upon thyroid allografts

Journal of Immunology

Volumn 167, Issue 3, 2001, Pages 1338-1346

  Tourneur, L ^a   Malassagne, B ^a   Batteux, F ^a   Fabre, M ^a   Mistou, S ^a   Lallemand, E ^a   Lores, P ^a   Chiocchia, G ^a  

^a Hôpital Cochin ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; LIGAND;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CYTOTOXIC T LYMPHOCYTE; GENE EXPRESSION; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOTHERAPY; MALE; MOUSE; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; STATISTICAL ANALYSIS; SUPPRESSOR CELL; THYROID FOLLICLE CELL; TRANSGENE;

EID: 0035421771     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.3.1338     Document Type: Article

References (39)

1. Fas ligand and immune evasion
2. The Fas death factor
3. Fas ligand-induced apoptosis as a mechanism of immune privilege
4. CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance
5. A role for CD95 ligand in preventing graft rejection
6. CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival
7. Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice
8. Cotransplantation of allogeneic islets with allogeneic testicular cell aggregates allows long-term graft survival without systemic immunosuppression
9. The role of Fas in autoimmune diabetes
10. Transgenic expression of CD95 ligand on islet β cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts
11. Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction
12. Accelerated rejection of Fas ligand-expressing heart grafts
13. Thyroid-stimulating hormone inhibits Fas antigen-mediated apoptosis of human thyrocytes in vitro
14. Fas (APO-1, CD95)-mediated apoptosis in thyroid cells is regulated by a labile protein inhibitor
15. Transgenic expression of Fas ligand on thyroid follicular cells prevents autoimmune thyroiditis
16. Thyroid allograft immunogenicity is reduced after a period in organ culture
17. Nitric oxide primes pancreatic β cells for Fas-mediated destruction in insulin-dependent diabetes mellitus
18. Apoptosis and thyroiditis
19. Dying (apoptosing?) for a consensus on the Fas death pathway in the thyroid
20. Opposing effects of transmembrane and soluble Fas ligand expression on inflammation and tumor cell survival
21. Fas ligand expression on islets as well as multiple cell lines results in accelerated neutrophilic rejection
22. Soluble Fas ligand is chemotactic for human neutrophilic polymorphonuclear leukocytes
23. Prevention of the induction of allospecific cytotoxic T lymphocyte and delayed-type hypersensitivity responses by ultraviolet irradiation of corneal allografts
24. Maximal proliferation of cytotoxic T lymphocytes requires reverse signaling through Fas ligand
25. + T cells
26. Examination of the sensitivity of T cells to Fas ligation: Induction of allospecific apoptosis
27. Differential ability of Th1 and Th2 T cells to express Fas ligand and to undergo activation-induced cell death
28. Differential ability of T cell subsets to undergo activation-induced cell death
29. Unequal death in T helper cell (Th) 1 and Th2 effectors: Th1, but not Th2, effectors undergo rapid Fas/FasL-mediated apoptosis
30. Expression and function of Fas antigen on activated murine B cells
31. Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance
32. Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance
33. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
34. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-β, PGE2, and PAF
35. Transcriptional and translational regulation of inflammatory mediator production by endogenous TGF-β in macrophages that have ingested apoptotic cells
36. Immunogenicity of apoptotic cells in vivo: Role of antigen load, antigen-presenting cells, and cytokines
37. Phagocyte recognition of cells undergoing apoptosis
38. + T cell- and IL-2-dependent mechanism
39. + T cells protect from autoimmune diabetes via bystander suppression using the IL-4/Stat6 pathway